CBD
Regen BioPharma Successfully Treats Rheumatoid Arthritis Using Cannabidiol (CBD) Based Immune Modulatory Treatments
Regen BioPharma Inc.
PR-M10-19-NI-009Oct 07, 2019
Positive Results
Lilly Presents Positive Results for Taltz® vs. Humira®in Patients with Active Psoriatic Arthritis
Eli Lilly and Company
PR-M06-19-NI-023Jun 18, 2019
Drug Development
Novartis Cosentyx® First to Show Efficacy in All Key Manifestations of Psoriatic Arthritis
Novartis
PR-M06-19-NI-020Jun 17, 2019
FDA Approval
UCB Given FDA Okay for Anti-Arthritis Drug
Emilie Branch
Pharma's Almanac
PAO-M04-19-NI-008Apr 02, 2019
FDA Approval
FDA Approves Treatment for Patients with a Type of Inflammatory Arthritis
U.S. Food & Drug Administration
PR-M04-19-NI-001Apr 01, 2019
Postmarketing Trial
FDA Responds to Safety Signal Reported in Required Postmarketing Trial for Xeljanz
U.S. Food & Drug Administration
PR-M02-19-NI-068Feb 28, 2019
FDA Approval
Fresh RA Treatment from Sanofi/Regeneron Approved
Emilie Branch
Pharma's Almanac
PAO-M05-17-NI-024May 23, 2017